|
Market Cap (6-Jun) $12,281,100 (923rd) |
Close (30-Jun) $0.125 |
Volume (30-Jun) 0 |
Shortsold (17-Apr) 8,415 (0.00%) (600th) |
|
52w High $0.058 |
52w Low $0.021 |
P/E - |
EPS 0 |
EMD released this announcement to the ASX on 8 December 2020, 9:56. The announcement is not marked as price sensitive, and is 22 page(s) in length and 3.51MB in size.
You can view all announcements from EMD and see how they appear on a price chart on the announcements page.
At the date of this announcement, EMD was 0.086% short sold according to ASIC data. It was ranked the 470th most shorted stock on the ASX. It remains ranked 600th as of the latest reported data (17 April 2025).
| Other Recent Announcements from EMD | |
|---|---|
| Trading Halt | 29 June 2023, 9:33 |
| Emyria Receives Ethics Approval for MDMA-assisted Therapy | 8 June 2023, 9:10 |
| Section 708A(5)(e) Notice | 10 May 2023, 18:37 |
| Product Launch Update | 8 December 2020, 9:56 |
| Emyria Sees Strong Interest in IBS Study | 3 December 2020, 9:43 |
| Emyria Launches Drug Development Program Based on RWE | 25 November 2020, 10:14 |
| Emyria Partners with Thought Leaders in Psychedelic Therapy | 19 November 2020, 9:22 |
You must be logged in to post a reply.
Emyria 